Pharmaceutical Research

, Volume 8, Issue 7, pp 933–937 | Cite as

Dodecyl N,N-Dimethylamino Acetate and Azone Enhance Drug Penetration Across Human, Snake, and Rabbit Skin

  • Jouni Hirvonen
  • J. Howard Rytting
  • Petteri Paronen
  • Arto Urtti
Article

Abstract

The effectiveness of the penetration enhancers, dodecyl N, N-dimethylamino acetate (DDAA) and Azone, on pretreated human epidermis for the permeation of model drugs, indomethacin, 5-fluorouracil, and propranolol-HCl, was studied in in vitro diffusion cells. Snakeskin (Elaphe obsoleta) and rabbit pinna skin were compared as possible models for human skin. The drug concentrations were analyzed by HPLC. With all skins and all model drugs, DDAA increased drug permeability at least as well as Azone, and in most cases it was a more effective permeation enhancer. The relative permeation improvements in human skin, snakeskin, and rabbit skin were 10- to 20-, 5- to 50-, and 20- to 120-fold, respectively. Tritiated water served as an indicator of skin condition. Its penetration in the skin samples was independent of the drugs used, and both penetration enhancers significantly increased the flux of tritiated water through all skins. Thus, DDAA and Azone significantly increased the permeation of lipophilic and hydrophilic model compounds. Rabbit pinna skin was a poor model for human skin in vitro, while snakeskin was much closer to human skin in terms of transdermal permeability. In most cases drug permeability decreased in the order rabbit ≫ human > or < snake.

penetration enhancer dodecyl N,N-dimethylamino acetate Azone percutaneous permeability animal models 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    A. M. Kligman. A biological brief on percutaneous absorption. Drug Dev. Ind. Pharm. 9:521–560 (1983).Google Scholar
  2. 2.
    B. W. Barry. Mode of action of penetration enhancers in human skin. J. Contr. Rel. 6:85–97 (1987).Google Scholar
  3. 3.
    M. Goodman and B. W. Barry. Lipid-protein-partitioning (LPP) theory of skin enhancer activity: Finite dose technique. Int. J. Pharm. 57:29–40 (1989).Google Scholar
  4. 4.
    O. Wong, J. Huntington, T. Nishihata, and J. H. Rytting. New alkyl N,N-dialkyl-substituted amino acetates as transdermal penetration enhancers. Pharm. Res. 6:286–295 (1989).Google Scholar
  5. 5.
    C. Fleeker, O. Wong, and J. H. Rytting. Facilitated transport of basic and acidic drugs in solutions through snakeskin by a new enhancer—dodecyl N,N-dimethylamino acetate. Pharm. Res. 6:443–448 (1989).Google Scholar
  6. 6.
    R. C. Wester and H. I. Maibach. Cutaneous pharmacokinetics: 10 steps to percutaneous absorption. Drug Metab. Rev. 14:169–205 (1983).Google Scholar
  7. 7.
    P. C. Rigg and B. W. Barry. Shed snake skin and hairless mouse skin as model membranes for human skin during permeation studies. J. Invest. Dermatol. 94:235–240 (1990).Google Scholar
  8. 8.
    M. Corbo, J.-C. Liu, and Y. W. Chien. Transdermal controlled delivery of propranolol from a multilaminate adhesive device. Pharm. Res. 6:753–758 (1989).Google Scholar
  9. 9.
    R. B. Stoughton. Enhanced percutaneous penetration with 1-dodecyl-azacycloheptan-2-one. Arch. Dermatol. 118:474–477 (1982).Google Scholar
  10. 10.
    K. Sugibayashi, K.-I. Hosoya, Y. Morimoto, and W. I. Higuchi. Effect of the absorption enhancer, Azone, on the transport of 5-fluorouracil across hairless rat skin. J. Pharm. Pharmacol. 37:578–580 (1985).Google Scholar
  11. 11.
    W. J. Lambert, W. I. Higuchi, K. Knutson, and S. L. Krill. Dose-dependent enhancement effects of Azone on skin permeability. Pharm. Res. 6:798–803 (1989).Google Scholar
  12. 12.
    R. D. Schoenwald and H. S. Huang. Corneal penetration behavior of β-blocking agents. I. Physicochemical factors. J. Pharm. Sci. 72:1266–1272 (1983).Google Scholar
  13. 13.
    P. W. Wertz and D. T. Downing. ω-Hydroxyacid derivatives in the epidermis of several mammalian species. Comp. Biochem. Physiol. B 93:265–269 (1989).Google Scholar

Copyright information

© Plenum Publishing Corporation 1991

Authors and Affiliations

  • Jouni Hirvonen
    • 1
  • J. Howard Rytting
    • 2
  • Petteri Paronen
    • 1
  • Arto Urtti
    • 1
  1. 1.Department of Pharmaceutical TechnologyUniversity of KuopioKuopioFinland
  2. 2.Department of Pharmaceutical ChemistryUniversity of KansasLawrence

Personalised recommendations